Harmony Biosciences Holdings, Inc. (HRMY) Free Cash Flow
Harmony Biosciences Holdings, Inc. (HRMY) free cash flow history and trends. Track FCF in Excel with MarketXLS.
Free Cash Flow Data
| Period | Free Cash Flow (USD) |
|---|---|
| 2020-12-31 | -$2.99M |
| 2021-12-31 | -$1.74M |
| 2022-12-31 | $144.29M |
| 2023-12-31 | $219.07M |
| 2024-12-31 | $218.67M |
| 2025-12-31 | $347.89M |
How HRMY compares with sector peers
| Symbol | Company | Free cash flow (latest fiscal year) |
|---|---|---|
| OGN | Organon & Co. | $414.00M |
| BIO | Bio-Rad Laboratories Inc. Class A | $374.60M |
| PODD | Insulet Corporation | $349.90M |
| BCRX | BioCryst Pharmaceuticals Inc. | $344.90M |
| HAE | Haemonetics Corporation | $260.44M |
These are five companies in the same sector as HRMY with a comparable annual free cash flow. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Harmony Biosciences Holdings, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Free_Cash_Flow("HRMY", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | HRMY | $42.21 | +0.09% | 1.60M |
| 3 | ||||
| 4 | ||||
| 5 |